Next Article in Journal
Rev Variation during Persistent Lentivirus Infection
Next Article in Special Issue
Efficacy of CMX001 as a Post Exposure Antiviral in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
Previous Article in Journal
Exploratory Spatial Analysis of in vitro Respiratory Syncytial Virus Co-infections
Previous Article in Special Issue
Monkeypox Virus Infections in Small Animal Models for Evaluation of Anti-Poxvirus Agents
Viruses 2010, 2(12), 2803-2830; doi:10.3390/v2122803
Review

Cidofovir Activity against Poxvirus Infections

*  and
Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KULeuven, Minderboredersstraat 10, B-3000 Leuven, Belgium
* Author to whom correspondence should be addressed.
Received: 10 November 2010 / Revised: 9 December 2010 / Accepted: 10 December 2010 / Published: 22 December 2010
(This article belongs to the Special Issue Antivirals Against Poxviruses)
Download PDF [315 KB, 23 December 2010; original version 22 December 2010]

Abstract

Cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, HPMPC] is an acyclic nucleoside analog approved since 1996 for clinical use in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients. Cidofovir (CDV) has broad-spectrum activity against DNA viruses, including herpes-, adeno-, polyoma-, papilloma- and poxviruses. Among poxviruses, cidofovir has shown in vitro activity against orthopox [vaccinia, variola (smallpox), cowpox, monkeypox, camelpox, ectromelia], molluscipox [molluscum contagiosum] and parapox [orf] viruses. The anti-poxvirus activity of cidofovir in vivo has been shown in different models of infection when the compound was administered either intraperitoneal, intranasal (aerosolized) or topically. In humans, cidofovir has been successfully used for the treatment of recalcitrant molluscum contagiosum virus and orf virus in immunocompromised patients. CDV remains a reference compound against poxviruses and holds potential for the therapy and short-term prophylaxis of not only orthopox- but also parapox- and molluscipoxvirus infections.
Keywords: cidofovir; poxviruses; acyclic nucleoside analog cidofovir; poxviruses; acyclic nucleoside analog
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Export to BibTeX |
EndNote


MDPI and ACS Style

Andrei, G.; Snoeck, R. Cidofovir Activity against Poxvirus Infections. Viruses 2010, 2, 2803-2830.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert